Human T-Cell Lymphotropic Virus 1, 2 (HTLV-1/HTLV-2) Differentiation
Also known as: HTLV-I/HTLV-II
Use
HTLV-1 infections can be confirmed and differentiated from HTLV-2 infections by using highly purified recombinant proteins or synthetic peptides which are either type common or type specific.
Special Instructions
This test should be used as supplementary testing for patients previously identified as reactive for antibodies to HTLV. It is not intended for primary screening or initial diagnostic purposes, but rather for confirmation following initial reactive results.
Limitations
This test is not suitable as a primary screening tool and is designed to be used as part of a confirmatory approach for patients with known reactivity to HTLV antibodies. It may not detect all cases of HTLV infection, especially in early stages or in cases with low viral titers. Additional confirmatory tests may be necessary depending on the findings and clinical symptoms of the patient.
Methodology
Immunoassay (Immunoblot)
Biomarkers
LOINC Codes
- 6432-9
- 26656-9
Result Turnaround Time
2-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
Red-top tube, gel-barrier tube, lavender-top (EDTA) tube, or yellow-top (ACD) tube
Storage Instructions
Refrigerate or freeze (Pour serum or plasma into plastic pour-off tube before freezing.). Stable 2°C to 8°C for seven days or -20°C for longer storage.
Causes for Rejection
Gross bacterial contamination; hemolysis; lipemia
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | longer than 7 days |